Unither’s Hydrogen-Electric R44 Takes Flight in Quebec

Why It Matters

If successful, hydrogen-electric helicopters could slash costs and maintenance for critical organ-transport logistics while reducing emissions, potentially transforming emergency medical supply chains and enabling higher-frequency, long-range rotorcraft missions.

Summary

United Therapeutics has flown a Robinson R44 helicopter retrofitted with a hydrogen-electric fuel cell system in Quebec and is conducting piloted test flights as it develops an aircraft to deliver human organs. CEO Martin Rothblatt said the program aims to pair hydrogen at 700 bar with a PowerCell fuel cell to match the roughly 250-nautical-mile range achieved by Beta Technologies’ battery-electric airframe while offering lower operating and maintenance costs. The company initially proved electric lift with a battery-powered R44 and then pivoted to hydrogen to overcome helicopters’ low lift-to-drag ratios and extend range. United Therapeutics plans to scale the concept for thousands of organ-delivery flights, emphasizing both decarbonization and cost efficiency.

Original Description

Unither Biolectronics, a subsidiary of United Therapeutics, has partnered with Tier 1 Engineering and Robinson Helicopter to modify an R44 with a hydrogen fuel-cell propulsion system.

Following a flight demonstration witnessed by Aviation Week at Bromont Airport in Quebec, Martine Rothblatt, United Therapeutics’ founder and CEO, briefed reporters on the company’s plan for using the modified helicopters to build out a zero-emissions network for delivery of manufactured organs from labs to hospitals.